ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitisZORYVE, a next-generation topical phosphodiesterase-4 ...
The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...
Introduction: Children diagnosed with atopic dermatitis (AD ... Despite elimination diets, only one-third of respondents saw mild improvement in AD lesions. Larger studies are needed to confirm ...
In January, the company announced what it called "not statistically superior" top-line results from mid-stage testing of ...
Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical ...
Organon is a strong investment opportunity with a high yield, diversified portfolio, steady performance, and transformative ...
The Punch Newspapers on MSN2d
Why parents shouldn’t use adult skincare products on babies – DermatologistsDermatologists have warned that applying adult skincare products and alcohol-based creams on babies puts them at risk of skin ...
Atopic dermatitis is increasing in prevalence and ... Topical corticosteroids are very helpful for mild-moderate disease; the weakest potency that is effective should be used, but moderate ...
The unique feline dermatological cases veterinary professionals can see at the clinic, plus how to approach them ...
Some children may outgrow it or will become more mild,” said Dr. Hartmann. Dr. Hartmann said because atopic dermatitis is a condition visible to other people, it tends to affect the patient’s ...
Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback